IGF1 and familial Alzheimer disease: The integration of these multiomics datasets through network-based approaches identified critical molecular hubs, including PIK3R1, IGF1, AKT1, IL6, JAK2, and STAT3, which represent promising therapeutic targets for addressing astrocyte dysfunction in fAD.